AAUM (Average Assets Under Management) of ₹5,369.64 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 66.8% | 64.9% | ▼ -2.0% |
| Healthcare Services | 27.2% | 27.6% | ▲ +0.5% |
| Chemicals & Petrochemicals | 2.3% | 2.3% | ● +0.1% |
| Healthcare Equipment & Supplies | 2.0% | 1.9% | ● -0.1% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 64.9% | 65.9% | ▲ +1.0% |
| Healthcare Services | 27.6% | 25.6% | ▼ -2.0% |
| Chemicals & Petrochemicals | 2.3% | 2.2% | ▼ -0.2% |
| Healthcare Equipment & Supplies | 1.9% | 1.8% | ▼ -0.1% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Corona Remedies Limited ₹142.35 Cr |
Pharmaceuticals & Biotechnology | 2.43% |
| 2 | Innova Captab Limited ₹96.64 Cr |
Pharmaceuticals & Biotechnology | 1.65% |
| 3 | Novartis India Limited ₹2.34 Cr |
Pharmaceuticals & Biotechnology | 0.04% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Healthcare Global Enterprises Limited ₹99.91 Cr |
Healthcare Services | 1.27% | 1.70% | +0.43% |
| 2 | Dr. Lal Path Labs Limited ₹95.38 Cr |
Healthcare Services | 1.47% | 1.62% | +0.15% |
| 3 | Acutaas Chemicals Ltd ₹295.15 Cr |
Pharmaceuticals & Biotechnology | 4.91% | 5.03% | +0.12% |
| 4 | Laurus Labs Limited ₹237.60 Cr |
Pharmaceuticals & Biotechnology | 3.96% | 4.05% | +0.09% |
| 5 | Sai Life Sciences Limited ₹152.45 Cr |
Pharmaceuticals & Biotechnology | 2.52% | 2.60% | +0.08% |
| 6 | Mankind Pharma Limited ₹100.15 Cr |
Pharmaceuticals & Biotechnology | 1.67% | 1.71% | +0.04% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited ₹653.98 Cr |
Pharmaceuticals & Biotechnology | 12.33% | 11.14% | -1.19% |
| 2 | Max Healthcare Institute Limited ₹223.15 Cr |
Healthcare Services | 4.31% | 3.80% | -0.51% |
| 3 | Aurobindo Pharma Limited ₹200.64 Cr |
Pharmaceuticals & Biotechnology | 3.90% | 3.42% | -0.48% |
| 4 | Apollo Hospitals Enterprise Limited ₹261.30 Cr |
Healthcare Services | 4.91% | 4.45% | -0.46% |
| 5 | Fortis Healthcare Limited ₹138.60 Cr |
Healthcare Services | 2.82% | 2.36% | -0.46% |
| 6 | Jupiter Life Line Hospitals Limited ₹126.80 Cr |
Healthcare Services | 2.55% | 2.16% | -0.39% |
| 7 | Aster DM Healthcare Limited ₹188.23 Cr |
Healthcare Services | 3.52% | 3.21% | -0.31% |
| 8 | Torrent Pharmaceuticals Limited ₹259.20 Cr |
Pharmaceuticals & Biotechnology | 4.72% | 4.42% | -0.30% |
| 9 | Biocon Limited ₹138.86 Cr |
Pharmaceuticals & Biotechnology | 2.67% | 2.37% | -0.30% |
| 10 | Cipla Limited ₹258.43 Cr |
Pharmaceuticals & Biotechnology | 4.67% | 4.40% | -0.27% |
35 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹653.98 Cr |
Pharmaceuticals & Biotechnology |
11.14%
|
|
| 2 |
₹464.58 Cr |
Pharmaceuticals & Biotechnology |
7.91%
|
|
| 3 |
₹295.15 Cr |
Pharmaceuticals & Biotechnology |
5.03%
|
|
| 4 |
₹261.30 Cr |
Healthcare Services |
4.45%
|
|
| 5 |
₹259.20 Cr |
Pharmaceuticals & Biotechnology |
4.42%
|
|
| 6 |
₹258.43 Cr |
Pharmaceuticals & Biotechnology |
4.40%
|
|
| 7 |
₹237.60 Cr |
Pharmaceuticals & Biotechnology |
4.05%
|
|
| 8 |
₹223.15 Cr |
Healthcare Services |
3.80%
|
|
| 9 |
₹200.64 Cr |
Pharmaceuticals & Biotechnology |
3.42%
|
|
| 10 |
₹188.23 Cr |
Healthcare Services |
3.21%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.